人形机器人价值链100强公司_86页_8mb

Morgan Stanley Research Summary: GenAI and Humanoid AI

Key Focus: AI robotics disruptors, market trends, and investment implications for GenAI/Embodied AI

1. Market Overview

• AI TAM Growth:

  • Global AI market reached $4tn in 2024, projected to grow 40% YOY to $5.6tn in 2025 (primarily led by GenAI).
  • GenAI KPIs: 40% revenue growth post-2025, with adoption expected to surpass enterprises in 2028.

• Key Drivers:

  • Foundation Models: Investment totaling $55bn to build more capable GenAI models.
  • AI Hardware (NVIDIA): SWOT analysis shows dominance in AI data centers but risks from competition.

2. Humanoid Robot TAM & Pipeline

• Market Trajectory:

  • TAM Growth: Estimated $1.2tn by 2030, with cumulative hardware spend equal to Tesla's GDP ($4tn) by 2040/50.
  • By 2040, humanoid revenues could reach $60bn annually, linked to industrial/service transformations.

• Key Players/BOTs:

  • Tesla: Optimus Gen2 costing $20k per unit, BOM ~$2k (20% reduction YoY).
  • Elon Musk highlighted key BOM cost reduction phases; safety focus is critical for consumer trust.

3. Integration/Market Mapping

• Industry Adoption:

  • EMEA plays catch-up in GenAI, with 58% acknowledging bias in AI adoption near 2025.
  • Estimated 800+ companies using GenAI tools (primarily adoption-focused), while 100% of major US farms using robots by 2040.

• Investment Themes:

  • Infrastructure: Vehicle automation + AG manufacturing in 2024 focus.
  • Consolidation: Strategic AI buyers include IBM, Microsoft, Tesla, Nvidia, Qualcomm.

4. Assessment & Outlook

• Total Addressable Market (TAM):

  • GenAI transaction opportunities (NYSE/MSE listing) reach 381 in 2024.

• Intellectual Property:

  • Patent filing surge (1,704 in 2024), indicating strong competitive positioning.

• Actionable Insights:

  • AI underutilization "remains underbanked opportunities" (critical adoption angle).
  • Focus on iteration cycles and